Robert Nelsen, Director, 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), bought 1,733,333 shares at $12.50 ($5.0M) on 2016-07-06, disclosed to the SEC on 2016-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,333,333 | $0 | 0.0% |
| 2 | $12.50 | 400,000 | $5.0M | 100.0% |
| Total | $2.88 avg | 1,733,333 | $5.0M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |